Global Non-Opioid Pain Treatment market report deals with copious of important market related aspects which are; market size estimations, company and market best practices, entry level strategies, market dynamics, positioning, segmentations, competitive landscaping and benchmarking, opportunity analysis, economic forecasting, industry-specific technology solutions, roadmap analysis, and in-depth benchmarking of vendor offerings. This industry analysis report is a window to the industry which describes what market definition, classifications, applications, engagements and market trends are. An excellent Non-Opioid Pain Treatment market research report provides the best professional in-depth study on the current state for the Healthcare industry.
Data Bridge Market Research analyses that the non-opioid pain treatment market which was USD 622.65 million in 2021, would rocket up to USD 807.32 million by 2029, and is expected to undergo a CAGR of 3.30% during the forecast period 2022 to 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Browse Full Report Along With Facts and Figures @ https://www.databridgemarketresearch.com/reports/global-non-opioid-pain-treatment-market
Market Overview:
Non-opioid pain relievers are a form of pain reliever that has been specifically created to manage mild to moderate pain. They're commonly used to treat neuropathic pain, cancer pain, orthopaedic and musculoskeletal pain, and other conditions. Medical cannabis, botulinum toxins, capsaicin derivatives, and other non-opioid pain treatments are among the most common.
COVID-19 Impact on Non-Opioid Pain Treatment Market
The impact of COVID-19 on the non-opioid pain therapy market is being actively monitored by the QMI team. The clinic's services were severely impacted by the nationwide lockdown and continued rise in infection rates across the country. Many pain and clinic services have seen a decrease in patient visits as a result of COVID-19, resulting in less client engagement. In COVID-19, several clinics and pain services saw a drop in the number of visits.
Recent Development
In January 2021, a Duke-led team of scientists developed a biocompatible surgical patch that delivers non-opioid medicines to the wound site for days before dissolving. The novel polymer patch administers a regulated release of a medication that blocks the enzyme COX-2 (cyclooxygenase-2,) which is responsible for inflammation and pain.
In July 2020, the Food and Drug Administration (FDA) in the United States has approved an 8 percent capsaicin patch for the treatment of neuropathic pain in individuals with diabetic peripheral neuropathy of the feet. The patch is a non-opioid, non-systemic, and topical pain therapy that is thought to be the sole way to deliver prescription-strength capsaicin to the patient's skin.Some of the major players operating in the micellar casein market are Milk Specialties Global, Arla Foods Ingredients Group P/S, U.S. Dairy Export Council, Leprino Foods Company, ProteinCo., Idaho Milk Products, Nutrimed Healthcare, AMCO Proteins, Informa PLC, LACTALIS Ingredients, Hoogwegt, Glanbia plc, Ingredia, NUTREND D. S.,FrieslandCampina, Fonterra Co-operative Group Limited, Noumi Limited, NEW CULTURE, and MEGGLE GmbH & Co. KG, among others.
Some of the major players operating in the non-opioid pain treatment market are:
l Eli Lilly and company (U.S.)
l Regeneron Pharmaceuticals Inc. (U.S.)
l Centrexion Therapeutics Corp. (U.S.)
l Acorda Therapeutics (U.S.)
l Biogen (U.S.)
l VM Biotech (U.S.)
l Novartis AG (Switzerland)
l Alder Biopharmaceuticals (U.S.)
l Sanofi (France)
l Pfizer Inc. (U.S.)
l GSK plc. (U.K.)
l Hisamitsu Pharmaceutical Co., Inc. (Japan)
l Clarion (U.S.)
l Endo Pharmaceuticals (Ireland)
l TEH SENG PHARMACEUTICAL MFG. CO., LTD. (Taiwan)
Browse Trending Reports:
https://www.databridgemarketresearch.com/reports/global-systemic-antibiotics-market
https://www.databridgemarketresearch.com/reports/global-melanoma-therapeutics-market
https://www.databridgemarketresearch.com/reports/global-urachal-cancer-market
https://www.databridgemarketresearch.com/reports/global-vulvodynia-treatment-market
https://www.databridgemarketresearch.com/reports/global-solid-organ-transplantation-market
https://www.databridgemarketresearch.com/reports/global-cervical-cancer-treatment-market
About Data Bridge Market Research:
An absolute way to predict what the future holds is to understand the current trend! Data Bridge Market Research presented itself as an unconventional and neoteric market research and consulting firm with an unparalleled level of resilience and integrated approaches. We are committed to uncovering the best market opportunities and nurturing effective information for your business to thrive in the marketplace. Data Bridge strives to provide appropriate solutions to complex business challenges and initiates an effortless decision-making process. Data Bridge is a set of pure wisdom and experience that was formulated and framed in 2015 in Pune.
Data Bridge Market Research has more than 500 analysts working in different industries. We have served more than 40% of the Fortune 500 companies globally and have a network of more than 5,000 clients worldwide. Data Bridge is an expert in creating satisfied customers who trust our services and trust our hard work with certainty. We are pleased with our glorious 99.9% customer satisfaction rating.
Contact Us: -
Data Bridge Market Research
US: +1 888 387 2818
United Kingdom: +44 208 089 1725
Hong Kong: +852 8192 7475
Email: – corporatesales@databridgemarketresearch.com
